Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-21

Clinical Trial Update: The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects [NA]

View source ↗

Summary

A completed clinical trial investigating the effect of sitagliptin (Januvia) on oxidative stress in obese adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Januvia (sitagliptin)

Snippet

Sponsor: University at Buffalo | Conditions: Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2022-07-21